# Session: sub_49c4f5c9:sess_488c2689

- **subagent_id**: `sub_49c4f5c9`
- **subagent_name**: `regulatory-reviewer`
- **session_id**: `sess_488c2689`
- **model_key**: `llm`
- **model_id**: `gemma-4-31b-it`
- **provider**: `openai_compat`
- **tools_granted**: `["Read", "Write", "Glob", "Grep"]`
- **accessible_paths**: `["/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations", "/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/protocols/v3_amendments.md", "/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/…[truncated 39 chars]`
- **context_size_max**: `307102`

## System Prompt

```
You are a medical affairs regulatory specialist reviewing clinical trial documents. Your task: read all three regulatory PDFs (cn_nmpa_2026.pdf, eu_ema_2026.pdf, us_fda_2026.pdf) in the regulations directory, and combine with the recruitment breakdown from the v3 amendments file. Produce a concise regulatory_map.md with: (1) study recruitment breakdown by country, (2) at least one key compliance requirement per country (CN, DE, US), citing exact section/clause numbers from the source PDFs. Output to notes/regulatory_map.md in the output directory. Be terse — plain bullets, no fluff.
```

## Timeline

## Turn 1 — user
Read all three regulatory PDFs in the regulations directory and the v3_amendments.md file. 

The v3_amendments.md already contains the confirmed recruitment breakdown:
- Total: 240 patients
- CN: 120, DE: 80, US: 40

From the regulatory PDFs, extract at least one key compliance requirement per count…[truncated 338 chars]

> _system-reminder_: Context usage: 2212/100000 tokens (2%).

## Turn 2 — assistant
### Tool Call: `Read`
- **file_path**: `regulations/cn_nmpa_2026.pdf`

### Tool Call: `Read`
- **file_path**: `regulations/eu_ema_2026.pdf`

### Tool Call: `Read`
- **file_path**: `regulations/us_fda_2026.pdf`

### Tool Call: `Read`
- **file_path**: `v3_amendments.md`

## Turn 3 — tool_result
_tool_call_id_: `chatcmpl-tool-bfbe4c3855d9ab54`

tool error: file_path must be an absolute path; got 'regulations/cn_nmpa_2026.pdf'. Use a path under one of your accessible roots.

## Turn 4 — tool_result
_tool_call_id_: `chatcmpl-tool-a3b308a102efc060`

tool error: file_path must be an absolute path; got 'regulations/eu_ema_2026.pdf'. Use a path under one of your accessible roots.

## Turn 5 — tool_result
_tool_call_id_: `chatcmpl-tool-98d1c0ef16640dbc`

tool error: file_path must be an absolute path; got 'regulations/us_fda_2026.pdf'. Use a path under one of your accessible roots.

## Turn 6 — tool_result
_tool_call_id_: `chatcmpl-tool-a64c33d846ca4fae`

tool error: file_path must be an absolute path; got 'v3_amendments.md'. Use a path under one of your accessible roots.

## Turn 7 — assistant
### Tool Call: `Glob`
- **pattern**: `**/*.pdf`

### Tool Call: `Glob`
- **pattern**: `**/*.md`

## Turn 8 — tool_result
_tool_call_id_: `chatcmpl-tool-99bbf26b4398a4b3`

/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf
/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/cn_n…[truncated 168 chars]

## Turn 9 — tool_result
_tool_call_id_: `chatcmpl-tool-9e11584fa27e41c1`

(no matches)

## Turn 10 — assistant
### Tool Call: `Glob`
- **path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/`
- **pattern**: `v3_amendments.md`

## Turn 11 — tool_result
_tool_call_id_: `chatcmpl-tool-a41af198d35e4e6d`

forbidden: path '/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/' is outside this agent's accessible scope.

## Turn 12 — assistant
### Tool Call: `Glob`
- **pattern**: `**/v3_amendments.md`

## Turn 13 — tool_result
_tool_call_id_: `chatcmpl-tool-a5244130b5c7953b`

(no matches)

## Turn 14 — assistant
### Tool Call: `Glob`
- **pattern**: `**/*.md`

## Turn 15 — tool_result
_tool_call_id_: `chatcmpl-tool-866c31c8a31b33b9`

(no matches)

## Turn 16 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/cn_nmpa_2026.pdf`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf`

## Turn 17 — tool_result
_tool_call_id_: `chatcmpl-tool-a33bbc9487dd3669`

parsed text too large for a single Read: 697829 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 18 — tool_result
_tool_call_id_: `chatcmpl-tool-9916d61a604b88e9`

parsed text too large for a single Read: 650508 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 19 — tool_result
_tool_call_id_: `chatcmpl-tool-9b1ab7301cc426c8`

parsed text too large for a single Read: 603298 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 20 — assistant
### Tool Call: `Grep`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/cn_nmpa_2026.pdf`
- **pattern**: `Section|Clause|Requirement`

### Tool Call: `Grep`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`
- **pattern**: `Section|Clause|Requirement`

### Tool Call: `Grep`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf`
- **pattern**: `Section|Clause|Requirement`

## Turn 21 — tool_result
_tool_call_id_: `chatcmpl-tool-913db02708b3b0c9`

grep error: ripgrep (rg) is not installed

## Turn 22 — tool_result
_tool_call_id_: `chatcmpl-tool-9e70456a618d1540`

grep error: ripgrep (rg) is not installed

## Turn 23 — tool_result
_tool_call_id_: `chatcmpl-tool-9ef56a45c7dff99d`

grep error: ripgrep (rg) is not installed

## Turn 24 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/cn_nmpa_2026.pdf`
- **limit**: `500`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`
- **limit**: `500`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf`
- **limit**: `500`

## Turn 25 — tool_result
_tool_call_id_: `chatcmpl-tool-9ef044548e7c864e`

1	--- Page 1 ---
2	National Medical Products Administration (NMPA)
3	Good Clinical Practice (GCP) Guidelines — 2026 Edition
4	NMPA Order No. 86 (revised 2026)  |  ■■■■■■■■■■■ 86 ■■2026 ■■■■■
5	Effective: 2026-03-01
6	CHAPTER I — GENERAL PROVISIONS / ■■■ ■■
7	Scope: These guidelines apply to all clin…[truncated 510884 chars]

## Turn 26 — tool_result
_tool_call_id_: `chatcmpl-tool-bab063da0a1cfcc3`

1	--- Page 1 ---
2	European Medicines Agency (EMA)
3	Clinical Trials Guideline — EMA/CHMP/ICH/135/1995 (rev. 2026)
4	Incorporating ICH E6(R3) Good Clinical Practice
5	Effective: 2026-01-15
6	SECTION I — SCOPE AND PRINCIPLES
7	This guideline applies to all clinical trials submitted via CTIS under
8	R…[truncated 510358 chars]

## Turn 27 — tool_result
_tool_call_id_: `chatcmpl-tool-9060a1344fd6c380`

1	--- Page 1 ---
2	U.S. Food and Drug Administration (FDA)
3	21 CFR Part 312 — Investigational New Drug Application (IND)
4	Incorporating ICH E6(R3) Good Clinical Practice Guidelines
5	Revised: 2026-02-01
6	SUBPART A — GENERAL PROVISIONS
7	Applicable to IND TR-2026-PHII-091-IND-4821 for compound-X42…[truncated 509781 chars]
